Skip to main content

Table 2 Twenty-seven common FDA approved drugs derived from signaling network analysis and super-GO analysis

From: Computational analysis to repurpose drugs for COVID-19 based on transcriptional response of host cells to SARS-CoV-2

Caffeine Lenalidomide Naproxen Sunitinib Talniflumate
Lovastatin Dextromethorphan Phenylbutazone Resveratrol Fostamatinib
Lidocaine Diclofenac Thalidomide Nimesulide Chloroquine
Gefitinib Chloroquine Naloxone Pazopanib  
Sorafenib Simvastatin Dasatinib Tofacitinib  
Nabumetone Imiquimod Lapatinib Afatinib